93 related articles for article (PubMed ID: 9253512)
21. Generation of melanoma-specific, cytotoxic CD4(+) T helper 2 cells: requirement of both HLA-DR15 and Fas antigens on melanomas for their lysis by Th2 cells.
Zennadi R; Abdel-Wahab Z; Seigler HF; Darrow TL
Cell Immunol; 2001 Jun; 210(2):96-105. PubMed ID: 11520076
[TBL] [Abstract][Full Text] [Related]
22. Detection of naturally processed and HLA-A1-presented melanoma T-cell epitopes defined by CD8(+) T-cells' release of granulocyte-macrophage colony-stimulating factor but not by cytolysis.
Maeurer MJ; Martin D; Elder E; Storkus WJ; Lotze MT
Clin Cancer Res; 1996 Jan; 2(1):87-95. PubMed ID: 9816095
[TBL] [Abstract][Full Text] [Related]
23. Effect of interleukin 1 receptor antagonist gene transduction on human melanoma xenografts in nude mice.
Weinreich DM; Elaraj DM; Puhlmann M; Hewitt SM; Carroll NM; Feldman ED; Turner EM; Spiess PJ; Alexander HR
Cancer Res; 2003 Sep; 63(18):5957-61. PubMed ID: 14522922
[TBL] [Abstract][Full Text] [Related]
24. Effect of interleukin-7 gene transfection into ovarian carcinoma cell line SKOV3 in vitro and in vivo.
Xie X; Ye DF; Chen HZ; Lu WG; Fu YF; Cheng B; Zhu H
Gynecol Oncol; 2004 Feb; 92(2):578-85. PubMed ID: 14766250
[TBL] [Abstract][Full Text] [Related]
25. The tumorigenicity of IL-2 gene-transfected murine M-3D melanoma cells is determined by the magnitude and quality of the host defense reaction: NK cells play a major role.
Schneeberger A; Koszik F; Schmidt W; Kutil R; Stingl G
J Immunol; 1999 Jun; 162(11):6650-7. PubMed ID: 10352282
[TBL] [Abstract][Full Text] [Related]
26. alpha-fetoprotein and interleukin-18 gene-modified dendritic cells effectively stimulate specific type-1 CD4- and CD8-mediated T-Cell response from hepatocellular carcinoma patients in Vitro.
Cao DY; Yang JY; Dou KF; Ma LY; Teng ZH
Hum Immunol; 2007 May; 68(5):334-41. PubMed ID: 17462500
[TBL] [Abstract][Full Text] [Related]
27. Double-copy bicistronic retroviral vector platform for gene therapy and tissue engineering: application to melanoma vaccine development.
Wiznerowicz M; Fong AZ; Mackiewicz A; Hawley RG
Gene Ther; 1997 Oct; 4(10):1061-8. PubMed ID: 9415312
[TBL] [Abstract][Full Text] [Related]
28. Towards endothelial-cell-directed cancer immunotherapy: in vitro expression of human recombinant cytokine genes by human and mouse primary endothelial cells.
Ojeifo JO; Su N; Ryan US; Verma UN; Mazumder A; Zwiebel JA
Cytokines Mol Ther; 1996 Jun; 2(2):89-101. PubMed ID: 9384693
[TBL] [Abstract][Full Text] [Related]
29. Gene transfer of the CD80 costimulatory molecule into ocular melanoma cells using a novel episomal vector.
Uno T; Chen PW; Murray TG; Podack ER; Ksander BR
Invest Ophthalmol Vis Sci; 1997 Nov; 38(12):2531-9. PubMed ID: 9375572
[TBL] [Abstract][Full Text] [Related]
30. Interleukin 17, a T-cell-derived cytokine, promotes tumorigenicity of human cervical tumors in nude mice.
Tartour E; Fossiez F; Joyeux I; Galinha A; Gey A; Claret E; Sastre-Garau X; Couturier J; Mosseri V; Vives V; Banchereau J; Fridman WH; Wijdenes J; Lebecque S; Sautès-Fridman C
Cancer Res; 1999 Aug; 59(15):3698-704. PubMed ID: 10446984
[TBL] [Abstract][Full Text] [Related]
31. [Study on transfer of interleukin-7 gene into ovarian carcinoma cells in vitro].
Cheng B; Chen HZ; Ye DF; Lu WG; Xie X
Zhonghua Fu Chan Ke Za Zhi; 2003 Apr; 38(4):199-202. PubMed ID: 12885363
[TBL] [Abstract][Full Text] [Related]
32. Simultaneous generation of CD8+ and CD4+ melanoma-reactive T cells by retroviral-mediated transfer of a single T-cell receptor.
Roszkowski JJ; Lyons GE; Kast WM; Yee C; Van Besien K; Nishimura MI
Cancer Res; 2005 Feb; 65(4):1570-6. PubMed ID: 15735047
[TBL] [Abstract][Full Text] [Related]
33. Identification of genes differentially expressed in melanoma sublines derived from a single surgical specimen characterised by different sensitivity to cytotoxic T-lymphocyte activity.
Kocher T; Schraml P; Spagnoli GC; Harder F; Heberer M
Schweiz Med Wochenschr; 2000 Apr; 130(17):617-24. PubMed ID: 10829299
[TBL] [Abstract][Full Text] [Related]
34. Cytokine-based gene therapy of human tumors. An overview.
Parmiani G; Arienti F; Sulé-Suso J; Melani C; Colombo MP; Ramakrishna V; Belli F; Mascheroni L; Rivoltini L; Cascinelli N
Folia Biol (Praha); 1996; 42(6):305-9. PubMed ID: 9158940
[TBL] [Abstract][Full Text] [Related]
35. Dendritic cells loaded with killed allogeneic melanoma cells can induce objective clinical responses and MART-1 specific CD8+ T-cell immunity.
Palucka AK; Ueno H; Connolly J; Kerneis-Norvell F; Blanck JP; Johnston DA; Fay J; Banchereau J
J Immunother; 2006; 29(5):545-57. PubMed ID: 16971810
[TBL] [Abstract][Full Text] [Related]
36. Phase I/II trial of melanoma therapy with dendritic cells transfected with autologous tumor-mRNA.
Kyte JA; Mu L; Aamdal S; Kvalheim G; Dueland S; Hauser M; Gullestad HP; Ryder T; Lislerud K; Hammerstad H; Gaudernack G
Cancer Gene Ther; 2006 Oct; 13(10):905-18. PubMed ID: 16710345
[TBL] [Abstract][Full Text] [Related]
37. Growth inhibition of interleukin-2 receptor gene-transduced peripheral blood lymphocytes on human ovarian cancer cells.
Ye D; Xie X; Lu W; Chen H; Cheng B
Chin Med J (Engl); 2001 Mar; 114(3):303-7. PubMed ID: 11780319
[TBL] [Abstract][Full Text] [Related]
38. Generation of cytotoxic effector lymphocytes by MLTC using tumor cells genetically modified to secrete interleukin-2.
Yamaguchi Y; Ohta K; Shimizu K; Minami K; Noma K; Hihara J; Toge T
Anticancer Res; 2001; 21(1B):669-77. PubMed ID: 11299824
[TBL] [Abstract][Full Text] [Related]
39. Inhibiting the growth of malignant melanoma by blocking the expression of vascular endothelial growth factor using an RNA interference approach.
Tao J; Tu YT; Huang CZ; Feng AP; Wu Q; Lian YJ; Zhang LX; Zhang XP; Shen GX
Br J Dermatol; 2005 Oct; 153(4):715-24. PubMed ID: 16181451
[TBL] [Abstract][Full Text] [Related]
40. Multicomponent gene therapy vaccines for lung cancer: effective eradication of established murine tumors in vivo with interleukin-7/herpes simplex thymidine kinase-transduced autologous tumor and ex vivo activated dendritic cells.
Sharma S; Miller PW; Stolina M; Zhu L; Huang M; Paul RW; Dubinett SM
Gene Ther; 1997 Dec; 4(12):1361-70. PubMed ID: 9472560
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
